Story thread · 4 reports / 2 sources

XORTX Announces Director Resignation

financialpost.com · 11dShare

CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that Anthony Giovinazzo is stepping down from the board of directors for personal reasons […]

First report: XORTX Appoints New Director — thestar.com, 13d